Friday, March 19, 2021
This conference has already taken place.
Description
esophageal and liver cancers are relatively infrequently seen outside of referral center. The experience of many physicians practicing outside of referral centers tends to be limited. This has resulted in limited knowledge base of the relevant literature and competence in treating them.
For pricing information, see pricing tab below.
Dates and Times
Start: 3/19/2021 12:00 AM
End: 3/20/2021 12:00 AM
Objectives
- To describe updates and emerging data pertinent to clinical decision making from recently completed clinical trials.
- To integrate recent data and employ the findings to optimize multi-disciplinary therapies of GI cancer patients.
- To identify unique challenges and novel opportunities associated with advanced GI cancer patients.
- To distinguish treatment options that would result in over- or under-treating patients.
- To consider role of immunotherapies in various GI malignancies.
- To evaluate different loco regional treatment approaches.
- To refine mutli-disciplinary approaches based on latest clinical evidence and thought leader insights.
Pricing
| Tier | Price |
|---|---|
| Industry Attendees | $100.00 |
| Physician Provider | $75.00 |
| Non-Physician Provider | $50.00 |
| NON-OSU Fellows and Residents | $50.00 |
| OSU APP’s and APP Fellows, Faculty/Staff | $0.00 |
Conference Files
| File | Link |
|---|---|
|
Agenda Click "Download" to see a copy of the conference agenda |
Download |
Speakers
Location
Columbus, OH
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.